215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes

215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes

T1D therapies must be proven safe for young children, who face unique diabetes management challenges. The safety and performance of the Omnipod® hybrid closed-loop (HCL) personalized model predictive control algorithm were assessed in those with T1D aged 2-5.9 y with A1C

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2019-06, Vol.68 (Supplement_1)
Hauptverfasser: BUCKINGHAM, BRUCE A., FORLENZA, GREGORY P., SHERR, JENNIFER, GALDERISI, ALFONSO, EKHLASPOUR, LAYA, LEE, JOON BOK, OCONNOR, JASON B., DUMAIS, BONNIE, HUYETT, LAUREN M., LAYNE, JENNIFER E., LY, TRANG T.
Format: Artikel
Sprache:eng
Schlagworte:
Carbohydrates
Children
Control algorithms
Diabetes
Diabetes mellitus
Diabetes mellitus (insulin dependent)
Pediatrics
Teenagers
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:T1D therapies must be proven safe for young children, who face unique diabetes management challenges. The safety and performance of the Omnipod® hybrid closed-loop (HCL) personalized model predictive control algorithm were assessed in those with T1D aged 2-5.9 y with A1C
ISSN:0012-1797
1939-327X
DOI:10.2337/db19-215-OR